Guardant Health
GH
#1043
Rank
NZ$40.87 B
Marketcap
NZ$304.60
Share price
-8.83%
Change (1 day)
178.63%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

ESG Reports

Thumbnail Guardant Health
 ESG Report 2024

ESG Report 2024

Language: English

View ESG Report
Thumbnail Guardant Health
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report